结核病战略和技术咨询小组：年度会议报告，瑞士日内瓦，2025年6月10日至11日

Annual meeting report, Geneva, Switzerland10–11 June, 2025 Strategic andTechnicalAdvisoryGroup for Annual meeting report, Geneva, Switzerland10–11 June, 2025 Strategic and Technical Advisory Group for Tuberculosis: annual meeting report, Geneva, Switzerland, 10-11June 2025 ISBN978-92-4-011599-6(electronic version)ISBN 978-92-4-011600-9 (print version) © World Health Organization2025 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0IGO licence (CCBY-NC-SA3.0IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes,providedthe workis appropriately cited, as indicated below. In any use of this work, there should be nosuggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is notpermitted. If you adapt the work, then you must license your work under the same or equivalent CreativeCommons licence. If you create a translation of this work, you should add the following disclaimer along with Any mediation relating to disputes arising under the licence shall be conducted in accordance with themediationrules of the World Intellectual Property Organization Suggested citation.Strategic and Technical Advisory Group for Tuberculosis: annual meeting report, Geneva,Switzerland, 10-11 June 2025.Geneva: World Health Organization;2025. Licence:CCBY-NC-SA3.0IGO. Cataloguing-in-Publication (CIP) data.CIP data are available athttps://iris.who.int/. Sales, rights and licensing.To purchase WHO publications, seehttps://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a thirdparty, such astables, figures or images, it is your responsibility to determine whether permission is needed for that reuse andto obtain permission from the copyright holder. The risk of claims resulting from infringement of any third- General disclaimers.The designations employed and the presentation of the material in this publication do notimply the expression of any opinion whatsoever on the part of WHO concerning the legal status ofany country,territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsedor recommended by WHOin preference to others of a similar nature that are not mentioned. Errors and All reasonable precautions have been taken by WHOto verify the information contained in this publication.However, the published material is being distributed without warranty of any kind, either expressed or implied.The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHObe This publication contains the report of the Strategic and Technical AdvisoryGroup for Tuberculosis and does not Contents role (Session 1)............................................................................................................................................3 2.1 Background........................................................................................................................................32.2Questions for STAG-TB.................................................................................................................62.3STAG-TB comments.....................................................................................................................62.4STAG-TB preamble.......................................................................................................................62.5STAG-TB recommendations........................................................................................................8 3.1Background................................................................................................................................103.2Towards anew, post-SDG global TB Strategy: a high-level roadmap of a suggested processand timeline...........................................................................................................................................113.3Questions to STAG-TB................................................................................................................123.4STAG-TB comments...................................................................................................................12 4.Planning for the 2026 STAG-TB meeting........................................................................................14 References.................................................................................................................................................15Annex 1. STAG-TB 2025 meeting agenda..................................